Patents by Inventor Daniel DeSantis
Daniel DeSantis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250223055Abstract: A satellite may include an optical component, and an optical adjustment device coupled to the optical component. The optical adjustment device may include a base, and an adjustment flexure carried by the base. The adjustment flexure may be moveable between an unflexed neutral position and a flexed first position, and between the unflexed neutral position and a flexed second position. The optical adjustment device may further include a rotatable drive shaft carried by the base, a drive cam carried by the rotatable drive shaft, a first cam follower and a second cam follower. The cam may cause the first and second cam followers to selectively move the adjustment flexure between the unflexed neutral position and the flexed first flexed position or the second flexed position.Type: ApplicationFiled: January 9, 2024Publication date: July 10, 2025Inventors: Aidan BRAWLEY, Samuel HAN, Ethan HUFFMAN, Daniel DeSANTIS, Alan AKERSTROM, James GUREGIAN, Damien MADDEN, John GORMAN
-
Patent number: 12178849Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.Type: GrantFiled: August 30, 2021Date of Patent: December 31, 2024Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Ri.MED FoundationInventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
-
Publication number: 20210386825Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.Type: ApplicationFiled: August 30, 2021Publication date: December 16, 2021Applicants: UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, Ri.MED FoundationInventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
-
Patent number: 11129875Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.Type: GrantFiled: January 7, 2019Date of Patent: September 28, 2021Assignees: UNIVERSITY OF PITTSBURGH—OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION, RI.MED FOUNDATIONInventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
-
Publication number: 20190209651Abstract: The present invention provides microparticles that induce the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.Type: ApplicationFiled: January 7, 2019Publication date: July 11, 2019Inventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
-
Patent number: 10195252Abstract: The present invention provides microparticles that deliver in vivo predictable release profiles of at least one chemokine to create a biomimetic chemokine concentration gradient that induces the migration of multipotent stem cells to the anatomical site of the microparticles. Various release profiles are demonstrated that depend upon the relative concentration of alginate in the chemokine-loaded microparticle. Local administration and/or intraarticular injection of the microparticles are useful in conditions such as osteoarthritis. Targeted systemic delivery of the alginate chemokine microparticles to distant anatomical sites subjected to autoimmune disease symptomology can be performed by encapsulation within liposomes having targeting ligands. Consequently, upon the creation of the appropriate chemokine gradient, multipotent stem cells will migrate to the distant anatomical site where the liposomes are attached.Type: GrantFiled: August 1, 2013Date of Patent: February 5, 2019Assignee: University Of Pittsburgh—Of The Commonwealth System of Higher EducationInventors: Steven R. Little, Riccardo Gottardi, Mintai Peter Hwang, Daniel DeSantis
-
Patent number: 9856941Abstract: A flywheel system including a rotor shaft. The rotor shaft includes an inner passage therethrough, and a dam with a central opening disposed on a first end of the inner passage. An outer passage surrounds the inner passage. The inner passage is open at a second end, and the outer passage is closed on an end surrounding the second end of the inner passage. The outer passage is open on an end surrounding the first end of the inner passage. Fluid flows into the inner passage at the first end, via the central opening of the dam. Rotation of the flywheel rotor causes the fluid to accumulate along a wall of the inner passage, and to propagate to the second end, where the fluid exits into the outer passage. The fluid propagates along the outer passage to the open end of the outer passage, where it is released.Type: GrantFiled: July 8, 2015Date of Patent: January 2, 2018Assignee: Beacon Power, LLCInventors: James Arseneaux, David Ansbigian, Daniel DeSantis, Norman Brackett
-
Publication number: 20170009845Abstract: A flywheel system including a rotor shaft. The rotor shaft includes an inner passage therethrough, and a dam with a central opening disposed on a first end of the inner passage. An outer passage surrounds the inner passage. The inner passage is open at a second end, and the outer passage is closed on an end surrounding the second end of the inner passage. The outer passage is open on an end surrounding the first end of the inner passage. Fluid flows into the inner passage at the first end, via the central opening of the dam. Rotation of the flywheel rotor causes the fluid to accumulate along a wall of the inner passage, and to propagate to the second end, where the fluid exits into the outer passage. The fluid propagates along the outer passage to the open end of the outer passage, where it is released.Type: ApplicationFiled: July 8, 2015Publication date: January 12, 2017Applicant: BEACON POWER, LLCInventors: James Arseneaux, David Ansbigian, Daniel DeSantis, Norman Brackett